Dec. 22, 2022

Brom Rector — Investing in Psychedelics (EP.138)

Brom Rector is the founder of Empath Ventures, a VC fund that in invests in early-stage psychedelics startups. Prior to founding Empath, Brom sent several years as a portfolio manager and quantitative researcher. Brom joins the show to discuss the...

Brom Rector is the founder of Empath Ventures, a VC fund that in invests in early-stage psychedelics startups.

Prior to founding Empath, Brom sent several years as a portfolio manager and quantitative researcher.

Brom joins the show to discuss the current state of the psychedelics industry, the lessons learned founding a VC fund, the differences between psychedelics and cannabis, and a whole lot more.

Important Links:

Show Notes:

  • How Brom became interested in psychedelic investing
  • Psychedelics and the mental health epidemic
  • Depoliticising psychedelics
  • Empath Ventures’ business model
  • How we can scientifically improve psychedelics
  • The influence of hippie culture
  • A contrarian view on Big Pharma
  • The potential benefits of ibogaine
  • The differences between cannabis and psychedelics
  • Do some people not react to psychedelics?
  • Brom’s thoughts on microdosing
  • Lessons learned from founding a VC company
  • The benefits of Rule 506(c)

Books Mentioned:

  • How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence; by Michael Pollan
  • Healing Back Pain: The Mind-Body Connection; by John E. Sarno MD